Objective: Neoadjuvant chemotherapy refers to systemic chemotherapy applied before local surgery or radiotherapy for malignant tumors. The level of certain tumor markers is an important indicator for assessing the efficacy of neoadjuvant chemotherapy. This study aimed to investigate the effect of serum CA19-9 levels on subsequent neoadjuvant chemotherapy in the treatment of gastric adenocarcinoma.
Methods: We collected 86 advanced gastric adenocarcinoma patients from January 2016 to May 2018. Patients received at least 2 cycles neoadjuvant chemotherapy with SOX (Oxaliplatin, S-1) before surgery. Effective chemotherapy was defined as producing CR or PR andineffective was defined as SD or PD. We analyze the role of serum CA19-9 level in predicting the effectiveness of neoadjuvant chemotherapy in patients with advanced gastric cancer.
Results: In total 86 patients, 28 patients had abnormal and 58 patients had normal serum CA19-9 levels. The positivity rate of pretreatment serum CA19-9 was higher when PR or CR was achieved (P=0.0005***). The area under the ROC curve (AUC) for CA19-9 levels was 0.720 (95% CI 0.610-0.829) (P=0.001**).
Conclusions: Measurements of CA19-9 may be helpful in monitoring the efficacy of neoadjuvant chemotherapy in the treatment of patients with advanced gastric cancer and also may be able to effectively predict this effect, thereby reducing unnecessary chemotherapy.
Keywords: CA19-9; SOX; gastric adenocarcinoma; neoadjuvant chemotherapy.
IJCEP Copyright © 2018.
Conflict of interest statement
Clinical Evaluation of CEA, CA19-9, CA72-4 and CA125 in Gastric Cancer Patients With Neoadjuvant ChemotherapyZ Sun et al. World J Surg Oncol 12, 397. PMID 25543664.Our results suggest that high preoperative serum levels of CA72-4 and CA19-9 are associated with higher risk of death, high pretreatment CEA levels (>50 ng/ml) may pre …
[Predicting Value of Serum CEA and CA19-9 in Neoadjuvant Chemotherapy for Advanced Gastric Carcinoma]JH Wang et al. Zhonghua Wei Chang Wai Ke Za Zhi 15 (12), 1273-6. PMID 23268276.The expressions of serum CEA and CA19-9 are closely associated with tumor progression and prognosis in advanced gastric cancer. However, further study should be done to e …
Phase I Study of Neoadjuvant Chemotherapy With S-1 and Oxaliplatin for Locally Advanced Gastric Cancer (Neo G-SOX PI)H Satake et al. ESMO Open 2 (1), e000130. PMID 28761726.Neoadjuvant chemotherapy with an SOX regimen was feasible in patients with locally advanced gastric cancer. The recommended phase II dose was determined to be oxaliplatin …
[Neoadjuvant Chemotherapy in Locally Advanced Gastric Adenocarcinoma. Preliminary Results]P Lasser et al. Chirurgie 115 (6), 365-72. PMID 2692993. - ReviewGastric adenocarcinoma locally advanced or located at the cardia, or of large size or with local lymphadenopathies are of bad prognosis. To improve the surgical results w …
[The Value of Adjuvant and Neoadjuvant Chemotherapy in Treatment of Stomach Carcinoma]C Ausch et al. Wien Klin Wochenschr 108 (16), 496-504. PMID 8967093. - ReviewThe incidence of gastric adenocarcinoma has decreased dramatically in most Western countries over the past five decades. However, the five-year survival rate remains poor …